藍色生物技術市場規模、佔有率和成長分析：按產品類型、技術、應用、最終用戶、分銷管道和地區分類－2026-2033年產業預測

2024 年全球藍色生物技術市場價值為 64.2 億美元，預計到 2033 年將從 2025 年的 69.5 億美元成長至 130 億美元，預測期（2026-2033 年）的複合年成長率為 8.2%。

藍色生物技術利用海洋生物豐富的化學潛力，開發創新產品和服務，在生物經濟中扮演著至關重要的角色。該領域致力於解決人類健康、糧食安全和永續材料等緊迫問題，具體實例包括海洋來源的治療藥物、藻類來源的Omega-3脂肪酸替代品和抗藥性工業酶。目前，基因組學、培養和篩檢等技術的進步正在推動該產業的發展，並提高了生物探勘和規模化生產的效率。人工智慧（AI）作為一種變革性力量，將海洋基因組學與數據分析相結合，簡化了發現和生產流程，使企業能夠最佳化生物程序並增強永續性。這些趨勢正在吸引對海藻和微藻類企業的投資，並促進永續實踐與商業性可行性相結合的生態系統的發展，同時，相關政策獎勵也為減少碳排放和循環經濟舉措提供了支持。

全球藍色生物技術市場促進因素

包括製藥、營養補充品、化妝品和環境應用在內的各個領域對海洋來源化合物日益成長的興趣，是全球藍色生物技術市場發展的關鍵驅動力。這種快速成長的興趣促使企業投資於海洋生物資源的探勘和規模化開發。同時，它也促進了學術機構與產業界之間的策略合作，推動了專用供應鏈和加工基礎設施的建立，並促進了商業性進程。隨著企業探索生物來源的創新活性分子，對產品差異化潛力和新應用開發的認知，推動了持續的投資和市場擴張，最終促成了市場的強勁成長。

全球藍色生物技術市場的限制因素

全球藍色生物技術市場對開發商面臨許多限制，由於不同司法管轄區法規結構的多樣性和不斷變化，導致時間和資源成本增加。複雜的許可流程、廣泛的安全和環境評估要求，以及新型生物產品上市路徑的不確定性，造成了戰略上的不確定性，可能抑制投資並阻礙商業化進程。中小企業尤其面臨不成比例的合規挑戰，限制了其發展和有效競爭的能力。因此，遵守複雜的法律和道德標準仍然是一個持續存在的障礙，最終削弱了市場發展勢頭，並限制了創新海洋生物技術技術的廣泛應用。

全球藍色生物技術市場趨勢

全球藍色生物技術市場正呈現強勁的創新趨勢，海洋衍生產品領域尤其關注生物來源的生物活性化合物、酵素和生物材料。這項轉變正推動新型營養保健品、藥用化妝品和藥品的發展。培養、發酵和萃取技術的進步，使得永續規模化生產成為可能，並充分利用了以往難以企及的分子多樣性。研究機構、新創公司和成熟公司之間的合作，正在加速從發現到上市的轉換。此外，消費者對天然和功能性海洋成分日益成長的需求，也推動了對供應鏈和產品差異化的投資，從而確保該領域的長期商業性永續性。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球藍色生物技術市場規模：依產品類型分類

• 生質燃料和生質能源
• 海洋來源藥物
• 營養保健品和機能性食品
• 生質塑膠和生物材料
• 其他

全球藍色生物技術市場規模：依技術領域分類

• 基因工程
• 生物資訊學和定序
• 海洋生物資源的探勘與開採
• 其他

全球藍色生物技術市場規模：按應用領域分類

• 醫療保健和製藥
• 農業和水產養殖
• 環境管理與生物修復
• 其他

全球藍色生物技術市場規模：依最終用戶分類

• 製藥和生物技術公司
• 研究機構和學術機構
• 工業和化工公司
• 其他

全球藍色生物技術市場規模：按分銷管道分類

• 直接B2B銷售
• 專業生物製品批發商
• 線上平台
• 其他

全球藍色生物技術市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Aker BioMarine
• PharmaMar
• CP Kelco
• Marinova
• Seaweed & Co.
• Cyanotech
• Algatech（Solabia）
• Cellana
• Fermentalg
• Corbion
• DSM-Firmenich
• BASF
• Symrise
• Novonesis（Novozymes）
• Lonza
• Aquapharm Biodiscovery
• Sea6 Energy
• GlycoMar
• MicroA
• Olmix Group

結論與建議

Global Blue Biotechnology Market size was valued at USD 6.42 Billion in 2024 and is poised to grow from USD 6.95 Billion in 2025 to USD 13.0 Billion by 2033, growing at a CAGR of 8.2% during the forecast period (2026-2033).

Blue biotechnology leverages the diverse chemical potential of marine organisms to develop innovative products and services, playing a crucial role in the bioeconomy. This sector addresses urgent challenges such as human health, food security, and sustainable materials, exemplified by marine-based therapeutics, algal omega-3 oil alternatives, and resilient industrial enzymes. The industry is currently evolving through technological advancements in genomics, cultivation, and screening, enhancing the efficiency of bioprospecting and scale-up processes. AI is a transformative force, streamlining discovery and production by integrating marine genomics with data analytics, allowing companies to optimize bioprocesses and improve sustainability. These trends attract investment in seaweed and microalgae operations, fostering an ecosystem where sustainable practices meet commercial viability, supported by policy incentives for carbon reduction and circular economy initiatives.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Blue Biotechnology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Blue Biotechnology Market Segments Analysis

Global blue biotechnology market is segmented by product type, technology focus, application, end-user, distribution channel and region. Based on product type, the market is segmented into Biofuels and Bioenergy, Marine-Derived Pharmaceuticals, Nutraceuticals and Functional Foods, Bioplastics and Biomaterials and Others. Based on technology focus, the market is segmented into Genetic Engineering, Bioinformatics and Sequencing, Marine Bioprospecting and Extraction and Others. Based on application, the market is segmented into Healthcare and Medicine, Agriculture and Aquaculture, Environmental Management and Bioremediation and Others. Based on end-user, the market is segmented into Pharmaceutical and Biotech Firms, Research and Academic Institutions, Industrial and Chemical Companies and Others. Based on distribution channel, the market is segmented into Direct B2B Sales, Specialty Biological Distributors, Online Platforms and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Blue Biotechnology Market

The growing fascination with marine-derived compounds for various sectors, including pharmaceuticals, nutraceuticals, cosmetics, and environmental applications, acts as a significant impetus for the Global Blue Biotechnology market. This burgeoning interest encourages businesses to invest in the exploration and scaling of marine bioresources. It fosters strategic collaborations between academic institutions and industry players, facilitates the creation of dedicated supply chains and processing infrastructure, and bolsters commercial initiatives. As companies seek innovative bioactive molecules from oceanic organisms, the perceived potential for product differentiation and exploration of new applications stimulates ongoing investment and market expansion, ultimately contributing to robust market growth.

Restraints in the Global Blue Biotechnology Market

The Global Blue Biotechnology market faces significant restraints due to the diverse and ever-changing regulatory frameworks present in different jurisdictions, which lead to increased time and resource costs for developers. Complex permitting processes, varied safety and environmental assessment requirements, and ambiguous pathways for introducing novel biological products create strategic uncertainties that may discourage investment and hinder commercialization efforts. Smaller companies, in particular, encounter disproportionate compliance challenges that restrict their ability to grow and compete effectively. Consequently, the necessity to navigate intricate legal and ethical standards remains a persistent obstacle, ultimately reducing market momentum and limiting widespread adoption of marine biotechnology innovations.

Market Trends of the Global Blue Biotechnology Market

The Global Blue Biotechnology market is experiencing a robust trend towards innovation in marine-derived products, focusing on bioactive compounds, enzymes, and biomaterials from marine organisms. This shift is fostering the development of new nutraceuticals, cosmeceuticals, and pharmaceuticals. Improved cultivation, fermentation, and extraction technologies are making it possible to scale production sustainably, tapping into previously unreachable molecular diversity. Collaborative efforts among research institutions, startups, and established companies are enhancing the transition from discovery to market. Additionally, increasing consumer demand for natural and functional marine ingredients is driving investments in supply chains and product differentiation, ensuring long-term commercial viability in the sector.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Blue Biotechnology Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Biofuels and Bioenergy
• Marine-Derived Pharmaceuticals
• Nutraceuticals and Functional Foods
• Bioplastics and Biomaterials
• Others

Global Blue Biotechnology Market Size by Technology Focus & CAGR (2026-2033)

• Market Overview
• Genetic Engineering
• Bioinformatics and Sequencing
• Marine Bioprospecting and Extraction
• Others

Global Blue Biotechnology Market Size by Application & CAGR (2026-2033)

• Market Overview
• Healthcare and Medicine
• Agriculture and Aquaculture
• Environmental Management and Bioremediation
• Others

Global Blue Biotechnology Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Pharmaceutical and Biotech Firms
• Research and Academic Institutions
• Industrial and Chemical Companies
• Others

Global Blue Biotechnology Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Direct B2B Sales
• Specialty Biological Distributors
• Online Platforms
• Others

Global Blue Biotechnology Market Size & CAGR (2026-2033)

• North America (Product Type, Technology Focus, Application, End-User, Distribution Channel)
  • US
  • Canada
• Europe (Product Type, Technology Focus, Application, End-User, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Technology Focus, Application, End-User, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Technology Focus, Application, End-User, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Technology Focus, Application, End-User, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Aker BioMarine
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PharmaMar
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CP Kelco
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Marinova
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Seaweed & Co.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cyanotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Algatech (Solabia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cellana
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fermentalg
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corbion
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DSM-Firmenich
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BASF
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Symrise
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novonesis (Novozymes)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aquapharm Biodiscovery
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sea6 Energy
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlycoMar
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olmix Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations